329 related articles for article (PubMed ID: 15728186)
41. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
42. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide.
Iwase H; Tanaka A; Hiki Y; Kokubo T; Ishii-Karakasa I; Kobayashi Y; Hotta K
J Biochem; 1996 Aug; 120(2):393-7. PubMed ID: 8889826
[TBL] [Abstract][Full Text] [Related]
43. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
Hiki Y; Horie A; Yasuda Y; Iwase H; Sugiyama S
Acta Otolaryngol Suppl; 2004 Dec; (555):28-31. PubMed ID: 15768794
[TBL] [Abstract][Full Text] [Related]
44. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2.
Iwasaki H; Zhang Y; Tachibana K; Gotoh M; Kikuchi N; Kwon YD; Togayachi A; Kudo T; Kubota T; Narimatsu H
J Biol Chem; 2003 Feb; 278(8):5613-21. PubMed ID: 12438318
[TBL] [Abstract][Full Text] [Related]
45. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
46. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA
J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070
[TBL] [Abstract][Full Text] [Related]
47. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
Xie L; Wang L; Huang J; Fan J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
[TBL] [Abstract][Full Text] [Related]
48. O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy.
Hiki Y
Clin Exp Nephrol; 2009 Oct; 13(5):415-423. PubMed ID: 19365705
[TBL] [Abstract][Full Text] [Related]
49. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
Kokubo T; Hashizume K; Iwase H; Arai K; Tanaka A; Toma K; Hotta K; Kobayashi Y
Nephrol Dial Transplant; 2000 Jan; 15(1):28-33. PubMed ID: 10607764
[TBL] [Abstract][Full Text] [Related]
50. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Sadaka C; Leroy V; Benhamou M; Novak J; Vrtovsnik F; Haddad E; Chintalacharuvu KR; Monteiro RC
J Am Soc Nephrol; 2004 Mar; 15(3):622-34. PubMed ID: 14978164
[TBL] [Abstract][Full Text] [Related]
51. Sialylation analysis of O-glycosylated sialylated peptides from urine of patients suffering from Schindler's disease by Fourier transform ion cyclotron resonance mass spectrometry and sustained off-resonance irradiation collision-induced dissociation.
Froesch M; Bindila L; Zamfir A; Peter-Katalinić J
Rapid Commun Mass Spectrom; 2003; 17(24):2822-32. PubMed ID: 14673833
[TBL] [Abstract][Full Text] [Related]
52. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
53. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients.
Allen AC; Bailey EM; Brenchley PE; Buck KS; Barratt J; Feehally J
Kidney Int; 2001 Sep; 60(3):969-73. PubMed ID: 11532091
[TBL] [Abstract][Full Text] [Related]
54. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Vu HL; Novak L; Julian BA; Tomana M; Wyatt RJ; Edberg JC; Alarcón GS; Kimberly RP; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2008 Feb; 118(2):629-39. PubMed ID: 18172551
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides.
Bondt A; Nicolardi S; Jansen BC; Stavenhagen K; Blank D; Kammeijer GS; Kozak RP; Fernandes DL; Hensbergen PJ; Hazes JM; van der Burgt YE; Dolhain RJ; Wuhrer M
Sci Rep; 2016 Jun; 6():27955. PubMed ID: 27302155
[TBL] [Abstract][Full Text] [Related]
56. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney--relation to Henoch-Schönlein-associated IgA nephropathy.
Sedivá A; Stejskal J; Bartůnková J; Smetana K; Gabius HJ
Folia Biol (Praha); 1999; 45(4):147-50. PubMed ID: 10732728
[TBL] [Abstract][Full Text] [Related]
57. Methods in enzymology: O-glycosylation of proteins.
Peter-Katalinić J
Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314
[TBL] [Abstract][Full Text] [Related]
58. Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.
Gomes MM; Wall SB; Takahashi K; Novak J; Renfrow MB; Herr AB
Biochemistry; 2008 Oct; 47(43):11285-99. PubMed ID: 18826328
[TBL] [Abstract][Full Text] [Related]
59. IgA nephropathy enigma.
Mestecky J; Novak J; Moldoveanu Z; Raska M
Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
[TBL] [Abstract][Full Text] [Related]
60. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
